Files in this Data Supplement:

• Supplemental file 1 - (Table S1) patient case summaries (clinical isolates of M. peregrinum type II, as well as culture source, associated clinical disease [where known], and geographical source, are listed); (Table S2) biochemical summaries (growth and biochemical test results for isolates listed in Table S1 are shown); (Fig. S3) HPLC results (HPLC mycolic acid profiles of M. peregrinum type II isolates and multiple related reference strains, including the bovine type strain of M. senegalense, are shown); (Fig. S4) MALDI-TOF-MS (a dendrogram that demonstrates the relatedness of M. peregrinum type II clinical strains and phylogenetically related species determined by mass spectroscopy); (Table S5) small nuclear polymorphisms (specific single-nucleotide polymorphisms [SNPs] that are present in the five sequevars of the 441-bp sequence of the hsp65 gene for isolates of M. peregrinum type II clinical strains and five related taxa are shown).
  MS Word document, 185K.